Liu Xiaoxiao

Dr. Liu Xiaoxiao

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2016 in Carbohydrate Polymers
Verified
Journal Article
Closed access
XLXiaoxiao Liu
Xiaoxiao Liu
JHJiejie Hao
Jiejie Hao
XSXindi Shan
Xindi Shan
XZXiao Zhang
Xiao Zhang
XZXiaoliang Zhao
Xiaoliang Zhao
LXLiu Xiaoxiao
Liu Xiaoxiao

12 May 2016 in Molecules
Verified
Journal Article
Open access
PDF file
LXLiu Xiaoxiao
Liu Xiaoxiao
YLYong Liu
Yong Liu
Jiejie HaoJiejie Hao
Jiejie Hao
XZXiaoliang Zhao
Xiaoliang Zhao
YLYinzhi Lang
Yinzhi Lang
Guangli YuGuangli Yu
Guangli Yu
The low-molecular-weight fucosylated chondroitin sulfate (LFCS) was prepared from native fucosylated chondroitin sulfate (FCS), which was extracted and isolated from sea cucumber Cucumaria frondosa, and the anti-cancer mechanism of LFCS on mouse Lewis lung carcinoma (LLC) was investigated. The results showed that LFCS remarkably inhibited LLC growth and metastasis in a dose-dependent manner. LFCS induced cell cycle arrest by increasing p53/p21 expression and apoptosis through activation of caspase-3 activity in LLC cells. Meanwhile, LFCS suppressed the expression of vascular endothelial growth factor (VEGF), increased the expression of tissue inhibitor of metalloproteinase-1 (TIMP-1) and downregulated the matrix metalloproteinases (MMPs) level. Furthermore, LFCS significantly suppressed the activation of ERK1/2/p38 MAPK/NF-κB pathway, which played a prime role in expression of MMPs. All of these data indicate LFCS may be used as anti-cancer drug candidates and deserve further study.

1 March 2020 in International Journal of Biological Macromolecules
Verified
Journal Article
Closed access
BLBingxi Li
Bingxi Li
HXHaiting Xu
Haiting Xu
XWXiaoqian Wang
Xiaoqian Wang
YWYuzhou Wan
Yuzhou Wan
NJNanfang Jiang
Nanfang Jiang
LXLiu Xiaoxiao
Liu Xiaoxiao